Clinical Trial Update: HR Versus RFA for Early Stage HCC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing H-Resection (HR) versus radiofrequency ablation (RFA) for early-stage hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 3 | Status: UNKNOWN